Welcome to our dedicated page for HAGERTY SEC filings (Ticker: HGTY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hagerty isn’t a typical insurer—it blends specialty vehicle coverage, valuation data, auctions, and the Hagerty Drivers Club into one ecosystem. That mix makes Hagerty’s SEC disclosures a rich source for details on loss ratios, membership growth, and auction margins that rarely surface elsewhere. If you have ever typed “Hagerty SEC filings explained simply� or wondered how founder-led strategy shows up in a 10-K, you’re in the right place.
What each filing reveals: the annual report (Hagerty annual report 10-K simplified) breaks out underwriting profitability and subscriber retention; the quarterly update (Hagerty quarterly earnings report 10-Q filing) tracks claims trends and new revenue streams; Form 8-K keeps you informed of acquisitions and concours expansions (Hagerty 8-K material events explained); and the proxy statement discloses incentive pay linked to loss ratio targets (Hagerty proxy statement executive compensation). Need to stay ahead of executive moves? Our feed delivers Hagerty insider trading Form 4 transactions and Hagerty executive stock transactions Form 4 within minutes, plus context on what those trades may signal.
How Stock Titan helps: AI-powered summaries turn dense paragraphs into plain-English takeaways, so understanding Hagerty SEC documents with AI takes minutes, not hours. AGÕæÈ˹ٷ½-time EDGAR monitoring posts every 10-Q, 10-K, 8-K, S-1, and Hagerty Form 4 insider transactions real-time as they land. Interactive tools compare segments quarter over quarter, flag unusual reserves, and surface trends for quick Hagerty earnings report filing analysis.
Whether you track combined ratios, membership churn, or insider buying ahead of auctions, this page provides complete, up-to-the-second coverage—saving you time while improving decision quality.
OCI N.V. and its Dutch subsidiaries OCI Intermediate B.V. and OCI Chemicals B.V. have filed a Schedule 13G disclosing a sizeable passive stake in Methanex Corporation (NASDAQ/TSX: MEOH). The filing, triggered by a June 27 2025 event date, shows beneficial ownership of 9,944,308 common shares, equal to 12.9 % of Methanex’s 77,339,520 shares outstanding as of June 30 2025.
All shares are held with shared voting power over 7,726,218 shares � subject to an undertaking not to vote more than 9.99 % of the company’s outstanding stock until Toronto Stock Exchange listing conditions are satisfied � and shared dispositive power over the full 9.94 million-share position. The reporting persons possess no sole voting or dispositive authority, underscoring the filing’s passive intent. Each entity certifies that the securities were not acquired for the purpose of influencing control, in line with Schedule 13G requirements.
The disclosure makes OCI � a Netherlands-based global producer of nitrogen, methanol and hydrogen products � one of Methanex’s largest known shareholders. While the filing does not announce any transaction terms or strategic plans, the scale of the stake (worth roughly US$450-500 million at recent prices) signals institutional confidence in Methanex’s methanol market outlook and could foreshadow future collaboration or corporate activity within the global methanol value chain.
Solid Power, Inc. (SLDP) � Form 4 insider filing
President & CEO John C. Van Scoter reported a Rule 16b transaction coded “F� on 06/30/2025 related to the vesting of restricted stock units (RSUs). The company withheld 42,841 common shares at $2.15 per share (� $92 k) to satisfy the executive’s tax obligation. Following the withholding, Van Scoter continues to own 4,040,859 common shares, all held directly. No derivative securities were acquired or disposed of, and no open-market sales or purchases occurred.
Because the transaction is strictly tax-related and represents roughly 1% of the executive’s holdings, it is generally viewed as neutral from a governance and signal perspective. Nevertheless, the filing reconfirms the CEO’s sizable equity stake, which aligns management incentives with shareholders.
Form 144 filed for Hagerty, Inc. (HGTY) discloses that Robert I. Kauffman/Aldel LLC intends to sell up to 4,600 common shares around 30 June 2025 through Merrill Lynch on the NYSE. Based on the filing’s stated market value of $46,276, the proposed sale represents less than 0.01 % of the company’s 90.0 million shares outstanding.
The seller originally acquired 3.5 million shares on 2 Dec 2021 as part of the PIPE financing linked to Hagerty’s SPAC business-combination. Over the preceding three months (17 Mar � 27 Jun 2025) the filer reported 53 separate open-market transactions totaling approximately 507,000 shares and $4.9 million in gross proceeds. The new notice therefore continues an established pattern of incremental insider disposals.
No operational, earnings, or strategic information about Hagerty is provided; the document is strictly a compliance notice under Rule 144. While the share volume is modest relative to the float, continuing insider sales may weigh on investor sentiment.
Hagerty (NYSE:HGTY) filed a Form 4 reporting routine insider activity by director Robert I. Kauffman.
- Between 06/25-06/27/2025, Kauffman, via Aldel LLC, sold 39,669 Class A shares at a weighted average price near $10.10.
- Sales were executed under a Rule 10b5-1 plan adopted 08/09/2024, signaling advance scheduling rather than opportunistic trading.
- Following the transactions, Kauffman retains 3,698,835 shares indirectly (Aldel LLC) and 67,302 shares directly.
The divestiture equals roughly 1 % of his total stake and $0.4 million in proceeds—levels considered non-material for Hagerty’s capitalization.
Director Robert I. Kauffman of Hagerty filed a Form 144 notice for the proposed sale of 7,432 shares of common stock with an aggregate market value of $75,212 through Merrill Lynch on the NYSE. The planned sale date is June 27, 2025.
The securities were originally acquired on December 2, 2021, as part of a PIPE financing connected to Hagerty's business combination. Kauffman's initial acquisition was 3.5 million shares.
Over the past three months (March-June 2025), Kauffman has conducted extensive trading activity through Aldel LLC, selling approximately 432,000 shares in multiple transactions, generating total proceeds of about $4.2 million. The trading has followed a 10b5-1 plan adopted on August 9, 2024.
The filing indicates Kauffman has no knowledge of material adverse information about Hagerty that hasn't been publicly disclosed. The company currently has 90,032,391 shares outstanding.
Form 144 Notice of Proposed Sale filed by Robert I. Kauffman, Director of Hagerty, indicating planned sale of 19,627 shares of common stock with an aggregate market value of $199,018 through Merrill Lynch on NYSE. The sale is scheduled for June 26, 2025.
Key transaction details:
- Original acquisition: 3.5 million shares acquired on December 2, 2021 through PIPE financing during business combination
- Extensive recent trading activity: Seller executed 47 separate sales transactions between March-June 2025, totaling approximately 425,000 shares with gross proceeds over $4 million
- Trading under 10b5-1 plan adopted on August 9, 2024
The filing confirms the seller has no knowledge of undisclosed material adverse information regarding Hagerty's operations. With 90 million shares outstanding, this proposed sale represents approximately 0.02% of total shares.
Form 144 filing reveals significant insider selling activity at Hagerty by Robert I. Kauffman and Aldel LLC. The filing indicates a proposed sale of 12,610 shares with an aggregate market value of $126,730, to be executed through Merrill Lynch on the NYSE around June 25, 2025.
Key details of the transaction:
- Original acquisition of 3.5 million shares occurred on December 2, 2021, through PIPE financing during business combination
- Extensive recent selling activity over past 3 months totaling approximately 400,000 shares between March-June 2025
- Largest single-day sales include 33,765 shares ($326,508) on May 7 and 31,110 shares ($315,455) on June 24
The company has 90,032,391 shares outstanding. This consistent selling pattern by a significant holder may indicate a systematic liquidation strategy, though represents a relatively small percentage of total shares outstanding.
Form 144 Notice of Proposed Sale filed by Robert I. Kauffman/Aldel LLC regarding Hagerty (NYSE: HGTY) common stock. The filing indicates a proposed sale of 31,110 shares with an aggregate market value of $315,455, to be executed through Merrill Lynch around June 24, 2025.
Key transaction details:
- Original acquisition: 3.5 million shares acquired on December 2, 2021 through PIPE financing during business combination
- Recent trading activity: Seller has been actively selling shares over past 3 months, with total sales of approximately 400,000 shares between March-June 2025
- Current outstanding shares: 90,032,391
This Form 144 represents continued liquidation of position by early investor. The systematic selling pattern over the past three months shows regular market transactions ranging from approximately 1,000 to 33,000 shares per day, with total proceeds exceeding $3.8 million during this period.
Director Robert I. Kauffman of Hagerty reported multiple sales of Class A Common Stock through his controlled entity Aldel LLC, executed under a pre-established Rule 10b5-1 trading plan from June 20-24, 2025:
- June 20: Sold 7,747 shares at average price of $9.82
- June 23: Sold 11,710 shares at average price of $10.02
- June 24: Sold 31,110 shares at average price of $10.14
Following these transactions, Kauffman maintains 3,738,504 shares indirectly through Aldel LLC, where he serves as manager with voting and investment control, and 67,302 shares directly. The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on August 9, 2024, demonstrating pre-planned, compliant insider trading activity.
Form 144 filing for Hagerty, Inc. (HGTY) discloses a notice of proposed insider sales by Robert I. Kauffman through Aldel LLC.
Proposed sale: 11,710 common shares to be executed around 06/23/2025 on the NYSE through Merrill Lynch, representing roughly 0.013% of the 90,032,391 shares outstanding. Estimated market value is $117,334.
Historical sales (last three months): The same insider has already disposed of �423,457 shares between 03/17/2025 and 06/20/2025 across 48 separate transactions, generating disclosed gross proceeds exceeding $4.0 million (sum of table line items). The individual transactions ranged from 1,149 to 33,765 shares per day.
The securities were originally acquired on 12/02/2021 as part of a PIPE investment related to Hagerty’s 2021 business-combination transaction. No gifts or non-cash consideration are reported.
The filer attests to the absence of undisclosed material adverse information and makes the customary Rule 10b5-1 representations.